Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk
Jun 26, 2026, 05:57

Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk

Ayse Bahar Keleşoğlu Dinçer, Rheumatology and Internal Medicine Consultant at The Pearl International Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Medicina, adding:

”Happy to share that our article, ‘Concordance and Relative Performance of the 2023 ACR/EULAR and Revised Sapporo Criteria in Antiphospholipid Syndrome and Analysis of Risk Factors for Recurrent Thrombosis: A Single-Center Cohort Study,’ is just published in Medicina, an SCIE Q1 journal.

This achievement reflects a great team effort, and I am grateful to all my co-authors for their collaboration, dedication, and expertise.”

Title: Concordance and Relative Performance of the 2023 ACR/EULAR and Revised Sapporo Criteria in Antiphospholipid Syndrome and Analysis of Risk Factors for Recurrent Thrombosis: A Single-Center Cohort Study

Authors: Mehmet Akif Baltaci, Emine Gozde Aydemir Guloksuz, Ruveyda Sak Inal, Ayse Tugenur Temiz Gencoglu, Gulnur Celik Yilmaz, Enver Caner Ceran, Samet Dal, Tugce Elmali Yazli, Recep Yilmaz, Asli Ciftci, Aslihan Avanoglu Guler, Hakan Apaydin, Cem Ozisler, Alper Sari, Sevinc Can Sandikci, Melih Pamukcu, Ayse Bahar Kelesoglu Dincer

Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk

Stay updated on all scientific advances with Hemostasis Today.